Abstract
Equitoxic doses of 5-(3-3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) and aryl-triazene derivatives (compounds all capable of inducing a marked increase in murine tumor cell immunogenicity) were studied for their effects on the host immune system. At different times after drug exposure the animals were tested for allograft responses, competence in producing lymphocytes active in lethal graft-versus-host disease, delayed-type hypersensitivity, humoral antibody production, and mitogen responsiveness. While some of the aryl-triazenes tested (DM-COOK DM-NO2) showed a pattern of immunodepression similar to that of DTIC, others were less (MIC, MM-COOK, MM-Cl) or far less (DM-Cl, MM-NO2) active than DTIC in impairing host immunocompetence, although all retained or even augmented their ability to induce chemical xenogenization.
Keywords: Lymphoma, Lymphoma Cell, Drug Exposure, Host Immune System, Humoral Antibody
Footnotes
This work was supported by “Progetto Finalizzato Controllo della Crescita Neoplastica” contracts no. 83.00815.96 and no. 83.00838.96 (CNR, Rome, Italy)
References
- 1.Bonmassar E, Bonmassar A, Vadlamudi S, Goldin A. Changes of L1210 leukemia in mice treated with 5-(3-3-dimethyl-1-triazeno)imidazole-4-carboxamide. Cancer Res. 1972;23:1446. [PubMed] [Google Scholar]
- 2.Bonmassar E, Fioretti MC, Nicolin A, Spreafico F. Drug-induced modifications of tumor-cell antigenicity. In: Spreafico F, Armon R, editors. Tumor-associated antigens and their specific immune responses. London: Academic; 1979. p. 251. [Google Scholar]
- 3.Delben F, Paoletti S, Manzin G, Nisi C. The influence of serum albumins on the decomposition rate of p-substituted 1-phenyl-3-methyl-triazenes and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide in near-physiological conditions. J Pharm Sci. 1981;70:892. doi: 10.1002/jps.2600700815. [DOI] [PubMed] [Google Scholar]
- 4.Elks J, Heyd DH (1943) Union of aryl nuclei. VI. Reactions with 1-aryl-3-3-dimethyltriazenes. J Chem Soc 441
- 5.Fioretti MC. Immunopharmacology of 5-(3,3-dimethyl-1-triazeno)-imidazolo)-imidazole-4-carboxamide (DTIC) Pharmacol Res Commun. 1975;7:481. [Google Scholar]
- 6.Fioretti MC, Nardelli B, Bianchi R, Nisi C, Sava G. Antigenic changes of a murine lymphoma by in vivo treatment with triazene derivatives. Cancer Immunol Immunother. 1981;11:283. [Google Scholar]
- 7.Giampietri A, Bonmassar E, Goldin A. Drug induced-modulation of immune responses in mice: effects of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide (Cy) J Immunopharmacol. 1978;1:61. doi: 10.3109/08923977809027330. [DOI] [PubMed] [Google Scholar]
- 8.Giampietri A, Bonmassar A, Puccetti P, Circolo A, Goldin A, Bonmassar E. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy. Cancer Res. 1981;41:681. [PubMed] [Google Scholar]
- 9.Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KSS. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst. 1974;53:1103. doi: 10.1093/jnci/53.4.1103. [DOI] [PubMed] [Google Scholar]
- 10.Jerne NK, Henry C, Nordin AA, Fujj H, Koros AMC, Lefkovits I. Plaque forming cell: methodology and theory. Transplant Rev. 1974;18:130. doi: 10.1111/j.1600-065x.1974.tb01588.x. [DOI] [PubMed] [Google Scholar]
- 11.Johnson AW (1946) Synthesis of 2-arylfurans. J Chem Soc 895 [PubMed]
- 12.Kerkhaert JA, Hofhuis FM, Willers JM. Effects of variation in time and dose of Cyclophosphamide injection on delayed hypersensitivity and antibody formation. Cell Immunol. 1977;29:232. doi: 10.1016/0008-8749(77)90318-5. [DOI] [PubMed] [Google Scholar]
- 13.Kolar GF. Synthesis of biologically active triazenes from isolable diazonium salts. Z Naturforsch [B] 1972;27:1183. doi: 10.1515/znb-1972-1016. [DOI] [PubMed] [Google Scholar]
- 14.Nardelli B, Contessa AR, Romani L, Sava G, Nisi C, Fioretti MC. Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. Cancer Immunol Immunother. 1984;16:157. doi: 10.1007/BF00205422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Puccetti P, Giampietri A, Fioretti MC. Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) Experientia. 1978;34:799. doi: 10.1007/BF01947335. [DOI] [PubMed] [Google Scholar]
- 16.Puccetti P, Romani L, Taramelli D, Bonmassar E, Fioretti MC. Drug-mediated changes of tumor cell immunogenicity and antigenicity. Int J Tissue React. 1982;4:189. [PubMed] [Google Scholar]